Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Davidson

Showing results (1381-1390 of 1,597) with videos related to

Pageof 160
Sort By:
Human Gene Therapy|August 28, 1998
Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liverA Bosch, P B McCray, K S Walters, et al.
Molecular Therapy. Methods & Clinical Development|August 22, 2024
Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterizationXueyuan Liu, Riffard Jean-Gilles, Julia Baginski, et al.
Haematologica|December 23, 2003
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group StudyKerri L Davidson, Maureen B Devaney, Jane E Tighe, et al.
Immunity|September 15, 1999
RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissuesR J Monroe, K J Seidl, F Gaertner, et al.
Genes & Development|August 8, 1998
The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrowL C Wang, W Swat, Y Fujiwara, et al.
Circulation|May 20, 1998
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]D B Mark, P A Cowper, S D Berkowitz, et al.
The Review of Scientific Instruments|January 3, 2016
A versatile retarding potential analyzer for nano-satellite platformsL Fanelli, S Noel, G D Earle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2022
Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulationRebecca C Ahrens-Nicklas, Luis Tecedor, Arron F Hall, et al.
The American Journal of Pathology|December 1, 1995
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brainL L Muldoon, G Nilaver, R A Kroll, et al.
The Journal of Pediatrics|April 13, 2011
Longitudinal assessment of hemoglobin oxygen saturation in preterm and term infants in the first six months of lifeCarl E Hunt, Michael J Corwin, Debra E Weese-Mayer, et al.
Pageof 160

Showing results (1381-1390 of 1,597) with videos related to

Sort By:
Pageof 160
Human Gene Therapy|August 28, 1998
Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liverA Bosch, P B McCray, K S Walters, et al.
Molecular Therapy. Methods & Clinical Development|August 22, 2024
Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterizationXueyuan Liu, Riffard Jean-Gilles, Julia Baginski, et al.
Haematologica|December 23, 2003
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group StudyKerri L Davidson, Maureen B Devaney, Jane E Tighe, et al.
Immunity|September 15, 1999
RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissuesR J Monroe, K J Seidl, F Gaertner, et al.
Genes & Development|August 8, 1998
The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrowL C Wang, W Swat, Y Fujiwara, et al.
Circulation|May 20, 1998
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]D B Mark, P A Cowper, S D Berkowitz, et al.
The Review of Scientific Instruments|January 3, 2016
A versatile retarding potential analyzer for nano-satellite platformsL Fanelli, S Noel, G D Earle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2022
Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulationRebecca C Ahrens-Nicklas, Luis Tecedor, Arron F Hall, et al.
The American Journal of Pathology|December 1, 1995
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brainL L Muldoon, G Nilaver, R A Kroll, et al.
The Journal of Pediatrics|April 13, 2011
Longitudinal assessment of hemoglobin oxygen saturation in preterm and term infants in the first six months of lifeCarl E Hunt, Michael J Corwin, Debra E Weese-Mayer, et al.
Pageof 160